These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 26626908)

  • 1. How effective is ustekinumab in controlling psoriatic arthritis?
    Bonifati C; Graceffa D
    Dermatol Ther; 2016 May; 29(3):155-9. PubMed ID: 26626908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flare of palmoplantar psoriasis with ustekinumab.
    Daniel BS; Baker C; Foley P
    Australas J Dermatol; 2020 Feb; 61(1):63-65. PubMed ID: 31372980
    [No Abstract]   [Full Text] [Related]  

  • 3. Worsening of Psoriatic Arthritis After Ustekinumab Treatment.
    Onsun N; Yalcin B; Sallahoglu K; Rezvani A
    Am J Ther; 2018; 25(3):e381-e382. PubMed ID: 29189317
    [No Abstract]   [Full Text] [Related]  

  • 4. The safety of ustekinumab for the treatment of psoriatic arthritis.
    López-Ferrer A; Laiz A; Puig L
    Expert Opin Drug Saf; 2017 Jun; 16(6):733-742. PubMed ID: 28441904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onset of psoriatic arthritis during ustekinumab treatment for psoriasis: a case series of seven patients.
    Jones BB; Millsop JW; Walsh JA; Krueger GG; Callis Duffin K
    Br J Dermatol; 2015 Jul; 173(1):272-4. PubMed ID: 25557081
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study.
    Chimenti MS; Ortolan A; Lorenzin M; Triggianese P; Talamonti M; Costa L; Caso F; Favero M; Teoli M; Galluzzo M; Scarpa R; Punzi L; Perricone R; Ramonda R
    Clin Rheumatol; 2018 Feb; 37(2):397-405. PubMed ID: 29302829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab.
    Čarija A; Ivić I; Marasović-Krstulović D; Puizina-Ivić N
    Rheumatology (Oxford); 2015 Nov; 54(11):2114-6. PubMed ID: 26242857
    [No Abstract]   [Full Text] [Related]  

  • 8. Myasthenia gravis after etanercept and ustekinumab treatment for psoriatic arthritis: A case report.
    Nicocia G; Bonanno C; Lupica A; Toscano A; Rodolico C
    Neuromuscul Disord; 2020 Mar; 30(3):246-249. PubMed ID: 32057636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of bullous pemphigoid during treatment of psoriatic onycho-pachydermo periostitis with ustekinumab.
    Nakayama C; Fujita Y; Watanabe M; Shimizu H
    J Dermatol; 2015 Oct; 42(10):996-8. PubMed ID: 26010891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study.
    Napolitano M; Costa L; Caso F; Megna M; Scarpa R; Balato N; Ayala F; Balato A
    Clin Rheumatol; 2017 Jul; 36(7):1589-1593. PubMed ID: 28567556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ustekinumab associated with flares of psoriatic arthritis.
    Stamell EF; Kutner A; Viola K; Cohen SR
    JAMA Dermatol; 2013 Dec; 149(12):1410-3. PubMed ID: 24132520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD study.
    Pugliese D; Daperno M; Fiorino G; Savarino E; Mosso E; Biancone L; Testa A; Sarpi L; Cappello M; Bodini G; Caprioli F; Festa S; Laino G; Maconi G; Mazzuoli S; Mocci G; Sartini A; D'Amore A; Alivernini S; Gremese E; Armuzzi A
    Dig Liver Dis; 2019 Jul; 51(7):972-977. PubMed ID: 30992173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
    Antoni CE; Kavanaugh A; Kirkham B; Tutuncu Z; Burmester GR; Schneider U; Furst DE; Molitor J; Keystone E; Gladman D; Manger B; Wassenberg S; Weier R; Wallace DJ; Weisman MH; Kalden JR; Smolen J
    Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is ustekinumab effective for psoriatic arthritis with insufficient response to initial treatment?
    Venegas-Iribarren S; Andino-Navarrete R
    Medwave; 2018 Mar; 18(2):e7174. PubMed ID: 29522505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New onset or transition of disease state of psoriatic arthritis during treatment with ustekinumab: A single-center retrospective study.
    Asahina A; Umezawa Y; Momose M; Honda H; Yanaba K; Nakagawa H
    J Dermatol; 2017 Dec; 44(12):1380-1384. PubMed ID: 28771778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase III Trial.
    Kavanaugh A; Puig L; Gottlieb AB; Ritchlin C; Li S; Wang Y; Mendelsohn AM; Song M; Zhu Y; Rahman P; McInnes IB;
    Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1739-49. PubMed ID: 26097039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroke under treatment with ustekinumab for psoriatic arthritis.
    Aboudiab M; Andréjak M; Husein T; Goëb V
    Rev Neurol (Paris); 2019 Apr; 175(4):271-272. PubMed ID: 30638925
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE).
    Iannone F; Santo L; Bucci R; Semeraro A; Carlino G; Paoletti F; Quarta L; Leucci P; Zuccaro C; Marsico A; Scioscia C; D'Onofrio F; Mazzotta D; Muratore M; Cantatore FP; Lapadula G
    Clin Rheumatol; 2018 Mar; 37(3):667-675. PubMed ID: 29411182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with ustekinumab in a Spanish cohort of patients with psoriasis and psoriatic arthritis in daily clinical practice.
    Almirall M; Rodriguez J; Mateo L; Carrascosa JM; Notario J; Gallardo F
    Clin Rheumatol; 2017 Feb; 36(2):439-443. PubMed ID: 27817126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2).
    Kavanaugh A; Puig L; Gottlieb AB; Ritchlin C; You Y; Li S; Song M; Randazzo B; Rahman P; McInnes IB
    Ann Rheum Dis; 2016 Nov; 75(11):1984-1988. PubMed ID: 27098404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.